These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6379413

  • 21. [Production of an intrahepatic portocaval fistula in the dog with liver cirrhosis and portal hypertension].
    Burgener FA, Gutierrez OH.
    Rofo; 1984 Sep; 141(3):327-32. PubMed ID: 6435201
    [Abstract] [Full Text] [Related]

  • 22. [Collaterals of portal hypertension running through the liver. Part 1. Paraumbilical vein].
    Itai Y, Kokubo T, Ohtomo K, Okada Y, Kokudo N, Itoh T, Katamoto T, Terano A.
    Rinsho Hoshasen; 1989 Aug; 34(8):865-70. PubMed ID: 2685408
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ultrasonic evaluation of portosystemic collateral circulation in portal hypertension.
    Sheth SG, Amarapurkar DN, Chopra KB, Mani SA, Mehta PJ.
    J Assoc Physicians India; 1996 Aug; 44(8):537-9. PubMed ID: 9251426
    [Abstract] [Full Text] [Related]

  • 25. Portal hemodynamics in cirrhotics with portal hypertension using color Doppler velocity profile.
    Huang J, Yin X, Lu M, Chen J, Liang L.
    Chin Med J (Engl); 1999 Jul; 112(7):627-31. PubMed ID: 11601258
    [Abstract] [Full Text] [Related]

  • 26. Pathophysiology of portal hypertension.
    Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC.
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [Abstract] [Full Text] [Related]

  • 27. [Correlation between hemodynamic parameters of the portal circulation in cirrhotic patients].
    Bretagne JF, Bourguet P, Morisot D, Duvauferrier R, Darnault P, Gastard J.
    Gastroenterol Clin Biol; 1985 Oct; 9(10):674-8. PubMed ID: 4065489
    [Abstract] [Full Text] [Related]

  • 28. Percutaneous transhepatic portography. III. Relationships between portosystemic collaterals and portal pressure in cirrhosis.
    Burcharth F, Sørensen TI, Andersen B.
    AJR Am J Roentgenol; 1979 Dec; 133(6):1119-22. PubMed ID: 116503
    [Abstract] [Full Text] [Related]

  • 29. [Azygos venous blood flow in portal hypertension].
    Kokudo N.
    Nihon Geka Gakkai Zasshi; 1988 Nov; 89(11):1860-8. PubMed ID: 3205251
    [Abstract] [Full Text] [Related]

  • 30. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
    Feng H, Zhang Z, Leng X, Li S, Zhu J, Du R.
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
    [Abstract] [Full Text] [Related]

  • 31. [Characteristics of extrahepatic collateral blood flow in patients with cirrhosis of the liver].
    Borisova NA, Ryzhkov VK, Gapchenko EM.
    Vestn Khir Im I I Grek; 1988 Apr; 140(4):17-22. PubMed ID: 3420743
    [Abstract] [Full Text] [Related]

  • 32. Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.
    Tanabe N, Ishii M, Sato Y, Akahane T, Kobayashi N, Gama H, Iwasaki T, Toyota T.
    Dig Dis Sci; 2000 Mar; 45(3):581-6. PubMed ID: 10749336
    [Abstract] [Full Text] [Related]

  • 33. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
    Pelkonen R, Kallio H, Suoranta H, Karonen SL.
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):496-502. PubMed ID: 7023164
    [Abstract] [Full Text] [Related]

  • 34. Porto-systemic collaterals in cirrhosis of the liver. Selective percutaneous transhepatic catheterization of the portal venous system in portal hypertension.
    Hoevels J, Lunderquist A, Tylén U, Simert G.
    Acta Radiol Diagn (Stockh); 1979 Aug; 20(6):865-77. PubMed ID: 546069
    [Abstract] [Full Text] [Related]

  • 35. Spontaneous reversal of portal blood flow demonstrated by percutaneous transhepatic catheterization: report of two cases.
    Takayasu K, Takashi M, Musha H, Ohnishi K, Omata M, Kobayashi C, Okuda K.
    Gastroenterology; 1982 Apr; 82(4):753-7. PubMed ID: 7060895
    [Abstract] [Full Text] [Related]

  • 36. Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension.
    Ishikawa T, Shiratsuki S, Matsuda T, Iwamoto T, Takami T, Uchida K, Terai S, Yamasaki T, Sakaida I.
    J Gastroenterol; 2014 Sep; 49(9):1333-41. PubMed ID: 24096983
    [Abstract] [Full Text] [Related]

  • 37. A novel canine model of portal vein stenosis plus thioacetamide administration-induced cirrhotic portal hypertension with hypersplenism.
    Lin D, Wu X, Ji X, Zhang Q, Lin Y, Chen W, Jin W, Deng L, Chen Y, Chen B, Li J.
    Cell Biochem Biophys; 2012 Jan; 62(1):245-55. PubMed ID: 21904911
    [Abstract] [Full Text] [Related]

  • 38. [The study of endotoxin levels in portal venous system in liver cirrhosis].
    Yamamoto Y, Sezai S, Sakurabayashi S, Yoshiura K, Sanui S, Morita T, Shimizu T, Yoshino K, Iwase T, Hirano M.
    Nihon Shokakibyo Gakkai Zasshi; 1990 Apr; 87(4):997-1002. PubMed ID: 2376908
    [Abstract] [Full Text] [Related]

  • 39. Obliteration of portal systemic shunts as therapy for hepatic encephalopathy in patients with non-cirrhotic portal hypertension.
    Ito T, Ikeda N, Watanabe A, Sue K, Kakio T, Mimura H, Tsuji T.
    Gastroenterol Jpn; 1992 Dec; 27(6):759-64. PubMed ID: 1468606
    [Abstract] [Full Text] [Related]

  • 40. Portosystemic collaterals are not prerequisites for the development of hepatic encephalopathy in cirrhotic rats.
    Hsin IF, Wang SS, Huang HC, Lee FY, Chan CY, Chang CC, Hsu CY, Lin HC, Lee SD.
    J Chin Med Assoc; 2012 Jan; 75(1):3-9. PubMed ID: 22240529
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.